|
1
|
Malumbres M and Barbacid M: Cell cycle,
CDKs and cancer: A changing paradigm. Nat Rev Cancer. 9:153–166.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Sherr CJ: Cancer cell cycles. Science.
274:1672–1677. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Cicenas J and Valius M: The CDK inhibitors
in cancer research and therapy. J Cancer Res Clin Oncol.
137:1409–1418. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Diaz-Moralli S, Tarrado-Castellarnau M,
Miranda A and Cascante M: Targeting cell cycle regulation in cancer
therapy. Pharmacol Ther. 138:255–271. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Sedlacek HH: Mechanisms of action of
flavopiridol. Crit Rev Oncol Hematol. 38:139–170. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Khalil HS, Mitev V, Vlaykova T, Cavicchi L
and Zhelev N: Discovery and development of seliciclib. How systems
biology approaches can lead to better drug performance. J
Biotechnol. 202:40–49. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Tong WG, Chen R, Plunkett W, Siegel D,
Sinha R, Harvey RD, Badros AZ, Popplewell L, Coutre S, Fox JA, et
al: Phase I and pharmacologic study of SNS-032, a potent and
selective Cdk2, 7, and 9 inhibitor, in patients with advanced
chronic lymphocytic leukemia and multiple myeloma. J Clin Oncol.
28:3015–3022. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Strebhardt K and Ullrich A: Targeting
polo-like kinase 1 for cancer therapy. Nat Rev Cancer. 6:321–330.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Murugan RN, Park JE, Kim EH, Shin SY,
Cheong C, Lee KS and Bang JK: Plk1-Targeted small molecule
inhibitors: Molecular basis for their potency and specificity. Mol
Cells. 32:209–220. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Kollareddy M, Zheleva D, Dzubak P,
Brahmkshatriya PS, Lepsik M and Hajduch M: Aurora kinase
inhibitors: Progress towards the clinic. Invest New Drugs.
30:2411–2432. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Boutros R, Lobjois V and Ducommun B: CDC25
phosphatases in cancer cells: Key players? Good targets? Nat Rev
Cancer. 7:495–507. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Lavecchia A, Di Giovanni C and Novellino
E: CDC25 phosphatase inhibitors: An update. Mini Rev Med Chem.
12:62–73. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Nigg EA and Nigg EA: Mitotic kinases as
regulators of cell division and its checkpoints. Nat Rev Mol Cell
Biol. 2:21–32. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Lindqvist A, van Zon W, Karlsson C and
Wolthuis RM: Cyclin B1-cdk1 activation continues after centrosome
separation to control mitotic progression. PLoS Biol. 5:e1232007.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Lindqvist A, Rodríguez-Bravo V and Medema
RH: The decision to enter mitosis: Feedback and redundancy in the
mitotic entry network. J Cell Biol. 185:193–202. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Dunphy WG: The decision to enter mitosis.
Trends Cell Biol. 4:202–207. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Porter LA and Donoghue DJ: Cyclin B1 and
CDK1: Nuclear localization and upstream regulators. Prog Cell Cycle
Res. 5:335–347. 2003.PubMed/NCBI
|
|
18
|
Harper JW and Elledge SJ: The DNA damage
response: Ten years after. Mol Cell. 28:739–745. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Krenning L, Feringa FM, Shaltiel IA, van
den Berg J and Medema RH: Transient activation of p53 in G2 phase
is sufficient to induce senescence. Mol Cell. 55:59–72. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Baus F, Baus F, Gire V, Fisher D, Piette J
and Dulić V: Permanent cell cycle exit in G2 phase after DNA damage
in normal human fibroblasts. EMBO J. 22:3992–4002. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Müllers E, Cascales HS, Jaiswal H, Saurin
AT and Lindqvist A: Nuclear translocation of Cyclin B1 marks the
restriction point for terminal cell cycle exit in G2 phase. Cell
Cycle. 13:2733–2743. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Lossaint G, Besnard E, Fisher D, Piette J
and Dulić V: Chk1 is dispensable for G2 arrest in response to
sustained DNA damage when the ATM/p53/p21 pathway is functional.
Oncogene. 30:4261–4274. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Hayashi MT and Karlseder J: DNA damage
associated with mitosis and cytokinesis failure. Oncogene.
32:4593–4601. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Dumontet C and Jordan MA:
Microtubule-binding agents: A dynamic field of cancer therapeutics.
Nat Rev Drug Discov. 9:790–803. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Perez EA: Microtubule inhibitors:
Differentiating tubulin-inhibiting agents based on mechanisms of
action, clinical activity, and resistance. Mol Cancer Ther.
8:2086–2095. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Risinger AL, Giles FJ and Mooberry SL:
Microtubule dynamics as a target in oncology. Cancer Treat Rev.
35:255–261. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Bhalla KN: Microtubule-Targeted anticancer
agents and apoptosis. Oncogene. 22:9075–9086. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Jordan MA and Wilson L: Microtubules as a
target for anticancer drugs. Nat Rev Cancer. 4:253–265. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Yi R, Saito K, Isegawa N and Shirasawa H:
Alteration of cell cycle progression by Sindbis virus infection.
Biochem Biophys Res Commun. 462:426–432. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Yoshida K, Morikawa T, Yokozuka N, Harada
S and Nishida A: Stereoselective synthesis of chiral
hydrocarbazoles via the catalytic diels-alder reaction of
siloxyvinylindole and cyclic Z-olefin. Tetrahedron Lett.
55:6907–6910. 2014. View Article : Google Scholar
|
|
31
|
Yuan Z, Lourenco SD, Sage EK, Kolluri KK,
Lowdell MW and Janes SM: Cryopreservation of human mesenchymal
stromal cells expressing TRAIL for human anti-cancer therapy.
Cytotherapy. 18:860–869. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Jang YJ, Ma S, Terada Y and Erikson RL:
Phosphorylation of threonine 210 and the role of serine 137 in the
regulation of mammalian polo-like kinase. J Biol Chem.
277:44115–44120. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Kellogg EH, Hejab NM, Howes S, Northcote
P, Miller JH, Díaz JF, Downing KH and Nogales E: Insights into the
distinct mechanisms of action of taxane and non-taxane microtubule
stabilizers from Cryo-EM structures. J Mol Biol. 429:633–646. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Hanwell MD, Curtis DE, Lonie DC,
Vandermeersch T, Zurek E and Hutchison GR: Avogadro: An advanced
semantic chemical editor, visualization, and analysis platform. J
Cheminform. 4:172012. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Becke AD: Density-functional
thermochemistry. III. The role of exact exchange. J Chem Phys.
98:5648–5652. 1998. View Article : Google Scholar
|
|
36
|
Lee C, Yang W and Parr RG: Development of
the colle-salvetti correlation-energy formula into a functional of
the electron density. Phys Rev B Condens Matter. 37:785–789. 1988.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Morris GM, Huey R, Lindstrom W, Sanner MF,
Belew RK, Goodsell DS and Olson AJ: AutoDock4 and autodocktools4:
Automated docking with selective receptor flexibility. J Comp Chem.
30:2785–2791. 2009. View Article : Google Scholar
|
|
38
|
Baker NA, Sept D, Joseph S, Holst MJ and
McCammon JA: Electrostatics of nanosystems: Application to
microtubules and the ribosome. Proc Natl Acad Sci USA.
98:10037–10041. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Vollmer CM, Ribas A, Butterfield LH,
Dissette VB, Andrews KJ, Eilber FC, Montejo LD, Chen AY, Hu B,
Glaspy JA, et al: P53 selective and nonselective replication of an
E1B-deleted adenovirus in hepatocellular carcinoma. Cancer Res.
59:4369–4374. 1999.PubMed/NCBI
|
|
40
|
Yasumura Y and Kawakita Y: A line of cells
derived from African green monkey kidney. Nippon Rinsho.
21:1209–1210. 1963.
|
|
41
|
Castedo M, Perfettini JL, Roumier T,
Andreau K, Medema R and Kroemer G: Cell death by mitotic
catastrophe: A molecular definition. Oncogene. 23:2825–2837. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Vitale I, Galluzzi L, Castedo M and
Kroemer G: Mitotic catastrophe: A mechanism for avoiding genomic
instability. Nat Rev Mol Cell Biol. 12:385–392. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Wei Y, Mizzen CA, Cook RG, Gorovsky MA and
Allis CD: Phosphorylation of histone H3 at serine 10 is correlated
with chromosome condensation during mitosis and meiosis in
tetrahymena. Proc Natl Acad Sci USA. 95:7480–7484. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Crosio C, Fimia GM, Loury R, Kimura M,
Okano Y, Zhou H, Sen S, Allis CD and Sassone-Corsi P: Mitotic
phosphorylation of histone H3: Spatio-Temporal regulation by
mammalian aurora kinases. Mol Cell Biol. 22:874–885. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
45
|
van Vugt MA and Medema RH: Getting in and
out of mitosis with polo-like kinase-1. Oncogene. 24:2844–2859.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Donzelli M and Draetta GF: Regulating
mammalian checkpoints through Cdc25 inactivation. EMBO Rep.
4:671–677. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Sakaue-Sawano A, Kobayashi T, Ohtawa K and
Miyawaki A: Drug-Induced cell cycle modulation leading to
cell-cycle arrest, nuclear mis-segregation, or endoreplication. BMC
Cell Biol. 12:22011. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Dalton WB, Yu B and Yang VW: P53
suppresses structural chromosome instability after mitotic arrest
in human cells. Oncogene. 29:1929–1940. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Shieh SY, Shieh SY, Ikeda M and Prives C:
DNA damage-induced phosphorylation of p53 alleviates inhibition by
MDM2. Cell. 91:325–334. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Chen W, Yi R, Vahed M, Ohno Y, Tian Z, Guo
S, Ma X, Win NN, Li Q, Tsubosaka A, et al: Novel chiral chalcone
analogs that induce M phase arrest and apoptosis in HeLa cells. Med
Chem. 9:74–82. 2019.
|
|
51
|
Colin DJ, Hain KO, Allan LA and Clarke PR:
Cellular responses to a prolonged delay in mitosis are determined
by a DNA damage response controlled by Bcl-2 family proteins. Open
Biol. 5:1401562014. View Article : Google Scholar
|
|
52
|
Dephoure N, Dephoure N, Zhou C, Villén J,
Beausoleil SA, Bakalarski CE, Elledge SJ and Gygi SP: A
quantitative atlas of mitotic phosphorylation. Proc Natl Acad Sci
USA. 105:10762–10767. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Orth JD, Loewer A, Lahav G and Mitchison
TJ: Prolonged mitotic arrest triggers partial activation of
apoptosis, resulting in DNA damage and p53 induction. Mol Biol
Cell. 23:567–576. 2012. View Article : Google Scholar : PubMed/NCBI
|
